Opinion

Video

Payor Considerations In MDS Management

The panelists highlight key takeaways for payors involved in MDS treatment.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
2 experts in this video
Related Content
Hidradenitis suppurativa. | Image Credit: Kristina Blokhin - stock.adobe.com
August 16th 2025

GLP-1s Show Promise for Patients With Hidradenitis Suppurativa and Obesity

Laura Joszt, MA
managed care cast logo
August 16th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
AJMC
August 16th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH
managed care cast logo
August 16th 2025

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
AJMC
August 16th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Mario Enrico Canonico, MD, PhD Judith Hsia, MD Shih-Ting Chiu, PhD Pu-Kai Tseng James O. Mudd, MD Joshua D. Remick, MD Bansi Patel, MS Ya-Hsiu Chuang, PhD Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Marc P. Bonaca, MD, MPH
Genetic factors may increase the risk of developing dilated cardiomyopathy in addition to covariates like age and sex. | Image Credit: AdobeStock_jaojormami.jpeg
August 16th 2025

Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation

Sabrina McCrear

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo